Latest filing published 24 Mar 2025 for ATEME, €10k. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Sereitra on record concern Ateme, in the capacity of chief executive. In total, 3 filings cover trades dated from 29 November 2024 to 20 March 2025.
No open-market sale appears; the market trades are 3 purchases worth €32k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €11k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month. Ninety days after publication, 3 purchases show a median change of -0.7%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
On 24 March 2025 came the latest disclosure, an open-market purchase for €10k in Ateme. Filings reach the AMF feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from AMF. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations